Would you please comment on the medical device industry as we move into 2013? The need for medical device manufacturers to have product recall plans in place was reaffirmed by the release of the latest figures on medical device unit recalls. According to the quarterly ExpertRECALL Index released August 22, 2012, over 123 million medical device units were recalled in the second quarter of 2012...
There are few industries as tightly interwoven with life and death issues as medical equipment. Getting everything right; from adherence to regulations to on-time product deliveries to perfectly performing products, is paramount. Complete transparency throughout the medical equipment supply chain is an absolute necessity. Transparency cannot be a part-time or partial commitment but rather, it must be an all-out endeavor to achieve safer and more effective patient healthcare.
The health care industry is adopting a set of standards to make supply chain easier for hospitals and Cook Medical is ready for the change. Almost ten years ago, Cook Medical realized all of its manufacturing companies were using different product numbering systems. The lack of standards caused confusion and inefficiency in shipping and tracking product.
FDA announces public-private partnership to develop regulatory science that will speed patient access to new medical device technologiesDecember 3, 2012 11:11 am | News | Comments
The U.S. Food and Drug Administration announced today that it is part of the first public-private partnership to promote medical device regulatory science with a focus on speeding the development, assessment, and review of new medical devices.
I tried hard to find a topic other than the coming medical device excise tax to write about, however, either my brain didn’t have any more room to fit another topic or there’s just not that much else going on in the medical device industry (which is much less likely). I was also hesitant to write the column because, unlike with the web, there is a period of time that passes from the moment I complete the column until the time it is published and mailed where the content is out of my hands while outside forces can wreak havoc on the topic and the timing of its appearance.
Given that the malfunction of a device can lead to fatality, the need to ensure these devices are safe and are monitored effectively is crucial. Any complaints on devices need to be monitored so that if there is a need to recall the device, it can be done effectively and quickly, without any further impact to patients.
New Legislation Would Establish Market-Based Pricing in Medicare for Home Medical Equipment and ServicesSeptember 25, 2012 2:11 pm | by PRNewswire-USNewswire | News | Comments
The American Association for Homecare endorses a bill introduced last week in the House of Representatives that would implement market-based pricing for home medical equipment and services such as oxygen therapy, wheelchairs, and other durable medical equipment and services.
Each Autumn, with an eye on the winter months ahead, squirrels gather nuts to prepare for the inevitable change. Hospitals, medical facilities, doctors and long term care facilities may be doing the same this Fall, stocking shelves and purchasing items from their wish list and budgets before a new tax on most medical products goes into effect.
It’s time to turn questions into answers. Ideas into accomplishments. Time to rise up and meet the challenges of a global regulatory environment.
Today, Representative Edward J. Markey (D-Mass.) and Senator Jeff Merkley (D-Ore.) sent a letter to the Food and Drug Administration (FDA) calling on the agency to overhaul and streamline the federal databases that provide information to the public about the safety of medical devices that rarely undergo clinical trials in humans before being sold on the market. In the absence of legislation that would close the current loophole...
Medical device firm Covidien plc (NYSE: COV) has recalled several lots of cuffed Shiley brand tracheostomy tubes, which are inserted into patients’ windpipes to help them breathe when they can not do so on their own. The recall followed customer complaints about leakage or disconnection between inner and outer cannulae during mechanical ventilation of patients.
Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical DevicesJuly 26, 2012 11:48 am | News | Comments
On July 10, 2012, the Food and Drug Administration released its proposed rule for Unique Device Identification (UDI) of medical devices in the United States. The system focuses on creating standardized device identifiers that are applied to packaging and devices...
The FDA scientist behind allegations of in-house surveillance and overlooked safety concerns at the federal watchdog agency is no stranger to lawsuits. One of the whistle-blowing scientists who accused the FDA of persecuting and spying on employees has a few lawsuits under his belt, a charge that may damage his credibility in an ongoing case against the federal watchdog agency. Radiologist Dr. Robert Smith, a member of the so-called "FDA 9," joined colleagues in suing the FDA and its leadership for alleged retaliation against them when they raised questions agency decisions about some mammogram and colonoscopy systems.
Healthcare Supply Chain Association (HSCA) President Curtis Rooney today released the following statement regarding FDA’s release of a proposed rule on a Uniform Device Identifier (UDI) for implantable medical devices...
MassDevice.com assesses thechance that the U.S. Senate will vote to repeal the medical device tax. Now that the U.S. Supreme Court has upheld healthcare reform, hopes for a repeal of the medical device tax contained in the law rest with the U.S. Senate and a bill sponsored by Sen. Orrin Hatch (R-Utah) to do away with the 2.3% levy. News Well, Medical Device Taxread more
In an MDLinx survey of U.S. primary care physicians taken Thursday following the Supreme Court’s upholding of the Affordable Care Act (ACA) ruling, 66.5 percent said that they did not believe the law could achieve its objective of 100 percent healthcare coverage for Americans.
Supreme Court Decision to Uphold Healthcare Law Means “Game On” for Health Industry: Crunch Time for Those Who Waited, Says PwCJune 29, 2012 9:51 am | News | Comments
Today’s Supreme Court ruling upholding the Affordable Care Act gives extra punch to the market forces pushing healthcare away from fee-for-service and re-injects a new sense of urgency into the transformation of the health industry, according to a report published today by the Health Research Institute (HRI) of PwC US.
While supporters and opponents of President Obama’s healthcare reform legislation let out boos or cheers for the recent decision of the United States Supreme Court, one industry will not be pleased, according to Kalorama Information. The healthcare market research publisher says that the medical device industry will face additional costs
Generation Opportunity President Paul T. Conway Statement: Scotus Health Care Decision's Impact on Young AmericansJune 28, 2012 2:19 pm | News | Comments
Generation Opportunity President Paul T. Conway, former Chief of Staff for the US Department of Labor and former Deputy Secretary of Health and Human Resources for the Commonwealth of Virginia, has issued the following statement regarding the Supreme Court's decision today on the Patient Protection and Affordable Care Act:
With the U.S. Supreme Court ruling upholding the constitutionality of the Affordable Care Act (ACA), Cook Medical now calls for the U.S. Senate to repeal the 2.3 percent medical device excise tax included in that legislation.
American Heart Association CEO Nancy Brown issued the following statement today on the U.S. Supreme Court's ruling upholding the Affordable Care Act: "The historic decision handed down today will benefit America's heart health for decades to come. Questions about the Affordable Care Act's constitutionality have overshadowed the law's progress. With this ruling, that uncertainty has finally been put to rest.
Healthcare Supply Chain Association (HSCA) President Curtis Rooney today released the following statement regarding the Supreme Court’s decision to uphold the Affordable Care Act: "Now that the Supreme Court has rendered its decision on the Affordable Care Act and the national conversation can return to healthcare reform centered on cost containment, hospitals and healthcare providers will rely more than ever on the billions of savings that their group purchasing organizations (GPOs) provide every year.
Following is a statement from John C. Lechleiter, Ph.D., chairman, president, and chief executive officer of Eli Lilly and Company, regarding today's U.S. Supreme Court ruling to uphold the Affordable Care Act: "Following today's decision by the U.S. Supreme Court on the Affordable Care Act,...
Cefepime:Label Change- Risk of Seizure in Patients Not Receiving Dosage Adjustments for Kidney ImpairmentJune 26, 2012 11:30 am | by U.S. Food & Drug Administration | News | Comments
Health care professionals should adjust the dosage of cefepime in patients with creatinine clearance less than or equal to 60 mL/min.
A new memorandum issued by the U.S. Office of Special Counsel (OSC) instructing federal agencies to ensure their electronic surveillance policies and practices do not deter whistleblowing “confirms” the FDA broke the law when it allegedly monitored the personal emails of...